SEARCH:
Print

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, April 17, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 

1.

Details of the   person discharging managerial responsibilities/person closely associated  

a)

Name

Gerard van Odijk

2.

Reason for the   notification

a)

Position/status

Chairman of the Board of Bavarian Nordic A/S

b)

Initial   notification/Amendment

Initial notification

3.

Details of the   issuer, emission allowance market participant, auction platform, auctioneer   or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the   transaction(s): section to be repeated for (i) each type of instrument; (ii)   each type of transaction; (iii) each date; and (iv) each place where   transactions have been conducted

a)

Description of   the financial instrument, type of instrument
 
 

Identification   code

Shares


 
  DK0015998017

b)

Nature of the transaction

Acquisition of shares (vesting of restricted stock   units)

c)

Price(s) and   volume(s)

Price(s)

Volume(s)

 

 

DKK 138.43

2,709

d)

Aggregated information

-           Aggregated   volume

-           Price

 

2,709

DKK 375,000.00

e)

Date of the   transaction

2021-04-17

f)

Place of the   transaction

Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities/person   closely associated  

a)

Name

Anders Gersel Pedersen

2.

Reason for the notification

a)

Position/status

Deputy Chairman   of the Board of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial   notification

3.

Details of the issuer, emission allowance market participant, auction   platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type   of instrument; (ii) each type of transaction; (iii) each date; and (iv) each   place where transactions have been conducted

a)

Description of the financial instrument, type of instrument
 
 

Identification code

Shares


 
  DK0015998017

b)

Nature of the transaction

Acquisition of   shares (vesting of restricted stock units)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 138.46

1,625

d)

Aggregated   information

-           Aggregated   volume

-           Price

 

1,625

DKK 225,000.00

e)

Date of the transaction

2021-04-17

f)

Place of the transaction

Outside a   trading venue

 

 

1.

Details of the person discharging managerial responsibilities/person   closely associated  

a)

Name

Erik G. Hansen

2.

Reason for the notification

a)

Position/status

Member of the   Board of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial   notification

3.

Details of the issuer, emission allowance market participant, auction   platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type   of instrument; (ii) each type of transaction; (iii) each date; and (iv) each   place where transactions have been conducted

a)

Description of the financial instrument, type of instrument
 
 

Identification code

Shares


 
  DK0015998017

b)

Nature of the transaction

Acquisition of   shares (vesting of restricted stock units)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 138.50

1,083

d)

Aggregated   information

-           Aggregated   volume

-           Price

 

1,083

DKK 150,000.00

e)

Date of the transaction

2021-04-17

f)

Place of the transaction

Outside a   trading venue

 

 

1.

Details of the person discharging managerial responsibilities/person   closely associated  

a)

Name

Frank Verwiel

2.

Reason for the notification

a)

Position/status

Member of the   Board of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial   notification

3.

Details of the issuer, emission allowance market participant, auction   platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type   of instrument; (ii) each type of transaction; (iii) each date; and (iv) each   place where transactions have been conducted

a)

Description of the financial instrument, type of instrument
 
 

Identification code

Shares


 
  DK0015998017

b)

Nature of the transaction

Acquisition of   shares (vesting of restricted stock units)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 138.50

1,083

d)

Aggregated   information

-           Aggregated   volume

-           Price

 

1,083

DKK 150,000.00

e)

Date of the transaction

2021-04-17

f)

Place of the transaction

Outside a   trading venue

 

 

1.

Details of the person discharging managerial responsibilities/person   closely associated  

a)

Name

Elizabeth McKee Anderson

2.

Reason for the notification

a)

Position/status

Member of the   Board of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial   notification

3.

Details of the issuer, emission allowance market participant, auction   platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type   of instrument; (ii) each type of transaction; (iii) each date; and (iv) each   place where transactions have been conducted

a)

Description of the financial instrument, type of instrument
 
 

Identification code

Shares


 
  DK0015998017

b)

Nature of the transaction

Acquisition of   shares (vesting of restricted stock units)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 138.50

1,083

d)

Aggregated   information

-           Aggregated   volume

-           Price

 

1,083

DKK 150,000.00

e)

Date of the transaction

2021-04-17

f)

Place of the transaction

Outside a   trading venue

 

 

1.

Details of the person discharging managerial responsibilities/person   closely associated  

a)

Name

Peter Kürstein

2.

Reason for the notification

a)

Position/status

Member of the   Board of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial   notification

3.

Details of the issuer, emission allowance market participant, auction   platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type   of instrument; (ii) each type of transaction; (iii) each date; and (iv) each   place where transactions have been conducted

a)

Description of the financial instrument, type of instrument
 
 

Identification code

Shares


 
  DK0015998017

b)

Nature of the transaction

Acquisition of   shares (vesting of restricted stock units)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 138.50

1,083

d)

Aggregated   information

-           Aggregated   volume

-           Price

 

1,083

DKK 150,000.00

e)

Date of the transaction

2021-04-17

f)

Place of the transaction

Outside a   trading venue

 

About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacture and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Strategic National Stockpile of a non-replicating smallpox vaccine, which has been approved by the FDA under the trade name JYNNEOS®, also for the protection against monkeypox. The vaccine is approved as a smallpox vaccine in Europe under the trade name IMVANEX® and in Canada under the trade name IMVAMUNE®. Our commercial product portfolio furthermore contains the market-leading vaccine Rabipur®/RabAvert® against rabies and Encepur® against tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, MVABEA®, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine based on an in-licensed capsid virus-like particle technology. The vaccine candidate, ABNCoV2, is currently being investigated in clinical trials. For more information visit www.bavarian-nordic.com.

Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600

Company Announcement no. 15 / 2021

Published on April 17, 2021, 12:00 CET